SWALES PHARMA CONSULTING LTD
Significant control: James Andrew Swales (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Swales Pharma Consulting Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Swales Pharma Consulting Ltd sell?
Registered activity: Management consultancy activities other than financial management (SIC 70229). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
SWALES PHARMA CONSULTING LTD is an active private limited company (company number 12332818) incorporated on 25 November 2019, registered in New Malden. Its registered activity is management consultancy activities other than financial management (SIC 70229). Latest micro accounts cover the period ending 30 November 2025, showing net assets of £42k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 45% on the prior period (£77k).
By net assets it sits in the top quarter of 15,133 comparable companies in Greater London (median £4,103, upper quartile £37k).
Ownership and control
- Dr James Andrew Swales
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 25 November 20196 yrs ago
- Next accounts due
- 30 August 2027in 305 days
- Confirmation statement due
- 9 December 2026in 41 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 70229
- Management consultancy activities other than financial management
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | £42k | — | — | £13k | — | — | 1 |
| 30 November 2024 | £77k | — | — | £16k | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £42,259 at 30 November 2025
- Net assets down 25% or more on the prior period-45.1% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.16
- Incorporated five or more years agoIncorporated 25 November 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 305 days
- Confirmation statement duein 41 days
- Accounts period endNet assets £42k · micro accounts
- Accounts period endNet assets £77k · micro accounts
- Incorporated
Similar companies in Greater London
- WELCAP LIMITEDKnoll Rise · inc. Nov 2019
- ATAR LEGAL SERVICES LTDEnfield · inc. Nov 2019
- FERACITY LTDLeatherhead · inc. Nov 2019
- ARGON INTERNATIONAL SOLUTIONS LTDKings Langley · inc. Nov 2019
- CANDLESTICK HOLDINGS LTDPotters Bar · inc. Nov 2019
- RAINBOW LANE LTDHarrow · inc. Nov 2019
All companies incorporated on 25 November 2019 · in Nov 2019.
Reminders for SWALES PHARMA CONSULTING LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.